Roger J. Garceau
Independent DirectorDr. Roger J. Garceau, M.D., FAAP, is an Independent Director of Protara Therapeutics, Inc. (formerly known as Proteon Therapeutics Inc.) since January 2020. He served as Chief Development Advisor of Entera Bio Ltd. since January 04, 2021 until April 2022 and served as its Director since March 2016 until September 2024. He served as an Interim Chief Executive Officer at Entera Bio Ltd. since August 10, 2020 until January 4, 2021 and served its Chief Development Advisor at of Entera Bio Ltd. since December 2016 until 2020. Dr. Garceau served as Chief Medical Officer and Executive Vice President of NPS Pharmaceuticals, Inc. since December 11, 2008 and January 1, 2013 respectively until February 2015. Previously, Dr. Garceau served as a Senior Vice President of Research & Development at NPS Pharmaceuticals, Inc. from December 11, 2008 to December 31, 2012 and also served as its Senior Vice President. Dr. Garceau joined Sanofi-aventis in 2002 where he served as Vice President of the New Products Group. Dr. Garceau had been worked with Sanofi-Aventis including served as its Vice President of Clinical Operations, Interim Head of North American Medical and Regulatory Affairs and Head of U.S. Medical Research. He led a team of over 200 professionals and oversaw the design and execution of over 50 sponsored studies in five different therapeutic areas. Dr. Garceau served as Director of ArTara Therapeutics, Inc. since January 2019 until January 2020. He has broad pharmaceutical industry experience. Prior to Sanofi-aventis, Dr. Garceau served with Pharmacia Corporation in global development and medical affairs from 1986 until 2002, where he successfully contributed to a number of marketing applications. He served as a Non-Executive Director of Enterome SA since December 9, 2016 until 2023. Dr. Garceau is a board-certified pediatrician. He is a Fellow of the American Academy of Pediatrics. Dr. Garceau holds Bachelor of Science in Biology from Fairfield University in Fairfield, Connecticut and a Doctorate of Medicine from the University of Massachusetts Medical School.
Positions
- Company NameProtara Therapeutics, Inc.Stock CodeTARAPositionIndependent DirectorColleagues
- JSJesse SheffermanCo-founder, CEO, President & Director
- LMLuke M. BesharIndependent Chairman of the Board
- JZJacqueline ZummoCo-Founder, Chief R&D Officer
- PFPatrick FabbioChief Financial Officer
- HFHannah FryVP, Principal Accounting Officer & Controller
- JOJustine O’MalleySenior Vice President of Investor Relations & Corporate Affairs
- GPGregory P. SargenIndependent Director
- CSCynthia SmithIndependent Director
